Blood pressure variability assessed by home measurements: A systematic review

Hypertension Research

Volumn 37, Issue 6, 2014, Pages 565-572

  Stergiou, George S ^a   Ntineri, Angeliki ^a   Kollias, Anastasios ^a   Ohkubo, Takayoshi ^b   Imai, Yutaka ^c   Parati, Gianfranco ^d,e  

^a UNIVERSITY OF ATHENS   (Greece)

^b TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

^e ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

cardiovascular prognosis; home blood pressure; self measurement; target organ damage; variability

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTERY INJURY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CLINICAL PROTOCOL; DISEASE ASSOCIATION; DISEASE COURSE; HEART INJURY; HEART RATE; HOME MONITORING; HUMAN; HYPERTENSION; KIDNEY INJURY; MORTALITY; PATHOGENESIS; PROGNOSIS; SYSTEMATIC REVIEW; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR DISEASES; OBSERVER VARIATION; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; OBSERVER VARIATION; RISK FACTORS; TREATMENT OUTCOME;

EID: 84900323798     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2014.2     Document Type: Article

References (47)

1. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour bloodpressure mean and variability to severity of target-organ damage in hypertension.J Hypertens 1987; 5: 93-98.
2. Hansen TW, Thijs L, Li Y, Boggia J, Kikuya M, Björklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA. International Database on AmbulatoryBlood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic valueof reading-to-reading blood pressure variability over 24hours in 8938 subjects from11 populations. Hypertension 2010; 55: 1049-1057.
3. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlöf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic bloodpressure, and episodic hypertension. Lancet 2010; 375: 895-905.
4. Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlö f B, Poulter NR, Sever PSASCOT-BPLA and MRC Trial Investigators. Effects of beta blockers andcalcium-channel blockers on within-individual variability in blood pressure and risk ofstroke. Lancet Neurol 2010; 9: 469-480.
5. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationshipbetween visit-to-visit variability in systolic blood pressure and all-cause mortality in thegeneral population: findings from NHANES III, 1988 to 1994. Hypertension 2011;57: 160-166.
6. Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, Inoue R, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Day-by-day variability of blood pressure andheart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension2008; 52: 1045-1050.
7. Stergiou GS, Parati G. How to best assess blood pressure? The ongoing debate onthe clinical value of blood pressure average and variability. Hypertension 2011; 57:1041-1042.
8. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, Kario K, Lurbe E, Manolis A, Mengden T, O'Brien E, Ohkubo T, Padfield P, Palatini P, Pickering T, Redon J, Revera M, Ruilope LM, Shennan A, Staessen JA, Tisler A, Waeber B, Zanchetti A, Mancia GESH Working Group on Blood Pressure Monitoring. EuropeanSociety of Hypertension guidelines for blood pressure monitoring at home: a summaryreport of the Second International Consensus Conference on Home Blood PressureMonitoring. J Hypertens 2008; 26: 1505-1526.
9. Stergiou GS, Nasothimiou EG. Home monitoring is the optimal method for assessingblood pressure variability. Hypertens Res 2011; 34: 1246-1248.
10. Hashimoto T, Kikuya M, Ohkubo T, Satoh M, Metoki H, Inoue R, Asayama K, Kanno A, Obara T, Hirose T, Hara A, Hoshi H, Totsune K, Satoh H, Sato H, Imai Y. Home bloodpressure level, blood pressure variability, smoking, and stroke risk in Japanese men: theOhasama study. Am J Hypertens 2012; 25: 883-891.
11. Asayama K, Kikuya M, Schutte R, Thijs L, Hosaka M, Satoh M, Hara A, Obara T, Inoue R, Metoki H, Hirose T, Ohkubo T, Staessen JA, Imai Y. Home blood pressurevariability as cardiovascular risk factor in the population of Ohasama. Hypertension2013; 61: 61-69.
12. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability inhome-measured blood pressure and heart rate: the Finn-Home Study. Hypertension2012; 59: 212-218.
13. Schutte R, Thijs L, Liu YP, Asayama K, Jin Y, Odili A, Gu YM, Kuznetsova T, Jacobs L, Staessen JA. Within-subject blood pressure level-not variability-predicts fatal andnonfatal outcomes in a general population. Hypertension 2012; 60: 1138-1147.
14. Matsui Y, Ishikawa J, Eguchi K, Shibasaki S, Shimada K, Kario K. Maximum value ofhome blood pressure: a novel indicator of target organ damage in hypertension.Hypertension 2011; 57: 1087-1093.
15. Fukui M, Ushigome E, Tanaka M, Hamaguchi M, Tanaka T, Atsuta H, Ohnishi M, Oda Y, Hasegawa G, Nakamura N. Home blood pressure variability on one occasion is a novelfactor associated with arterial stiffness in patients with type 2 diabetes. Hypertens Res2013; 36: 219-225.
16. Ushigome E, Fukui M, Hamaguchi M, Senmaru T, Sakabe K, Tanaka M, Yamazaki M, Hasegawa G, Nakamura N. The coefficient variation of home blood pressure is a novelfactor associated with macroalbuminuria in type 2 diabetes mellitus. Hypertens Res2011; 34: 1271-1275.
17. Nishimura M, Kato Y, Tanaka T, Todo R, Tone A, Yamada K, Ootani S, Kawabe Y, Yoshizumi H, Hoshiyama Y. Significance of estimating the glomerular filtration rate forthe management of hypertension in type 2 diabetes with microalbuminuria. HypertensRes 2013; 36: 705-710.
18. Hoshide S, Yano Y, Shimizu M, Eguchi K, Ishikawa J, Kario K. Is home blood pressurevariability itself an interventional target beyond lowering mean home blood pressureduring anti-hypertensive treatment? Hypertens Res 2012; 35: 862-866.
19. Okada T, Matsumoto H, Nagaoka Y, Nakao T. Association of home blood pressurevariability with progression of chronic kidney disease. Blood Press Monit 2012; 17:1-7.
20. Ishikura K, Obara T, Kato T, Kikuya M, Shibamiya T, Shinki T, Ikeda U, Kobayashi Y, Metoki H, Mano N, Kuriyama S, Ohkubo T, Imai Y. J-HOME-Morning Study Group.Associations between day-by-day variability in blood pressure measured at home andantihypertensive drugs: the J-HOME-Morning study. Clin Exp Hypertens 2012;34: 297-304.
21. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Factors affecting the variability ofhome-measured blood pressure and heart rate: the Finn-home study. J Hypertens2010; 28: 1836-1845.
22. Kato T, Kikuya M, Ohkubo T, Satoh M, Hara A, Obara T, Metoki H, Asayama K, Hirose T, Inoue R, Kanno A, Totsune K, Hoshi H, Satoh H, Imai Y. Factors associated withday-by-day variability of self-measured blood pressure at home: the Ohasama study.Am J Hypertens 2010; 23: 980-986.
23. Imai Y, Nishiyama A, Sekino M, Aihara A, Kikuya M, Ohkubo T, Matsubara M, Hozawa A, Tsuji I, Ito S, Satoh H, Nagai K, Hisamichi S. Characteristics of bloodpressure measured at home in the morning and in the evening: the Ohasama study.J Hypertens 1999; 17: 889-898.
24. Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, Wada T. Day-by-dayvariability of home blood pressure in patients with chronic kidney disease. Nihon JinzoGakkai Shi 2008; 50: 588-596.
25. Kawabe H, Kanda T, Hirose H, Saito I. Variability of home blood pressure measurementsbetween first and second measurements on one occasion, and factors related tovariability. Clin Exp Hypertens 2012; 34: 237-242.
26. Johansson JK, Kronholm E, Jula AM. Variability in home-measured blood pressure andheart rate: associations with self-reported insomnia and sleep duration. J Hypertens2011; 29: 1897-1905.
27. Cacciolati C, Tzourio C, Hanon O. Blood pressure variability in elderly persons withwhite-coat and masked hypertension compared to those with normotension andsustained hypertension. Am J Hypertens 2013; 26: 367-372.
28. Schneider RH, Egan BM, Johnson EH, Drobny H, Julius S. Anger and anxiety inborderline hypertension. Psychosom Med 1986; 48: 242-248.
29. Staessen JA, Fagard R, Amery A. Life style as a determinant of blood pressure in thegeneral population. Am J Hypertens 1994; 7: 685-694.
30. Matsui Y, O'Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K. Combinedeffect of angiotensin II receptor blocker and either a calcium channel blockeror diuretic on day-by-day variability of home blood pressure: the JapanCombined Treatment With Olmesartan and a Calcium-Channel Blocker VersusOlmesartan and Diuretics Randomized Efficacy Study. Hypertension 2012; 59:1132-1138.
31. Tamura K, Shibuya K, Takeshita Y, Koide Y, Tokita Y, Umemura S. Questionable linkbetween normo-to microalbuminuria and home-measured blood pressure variability inhypertension. Hypertens Res 2012; 35: 802-804.
32. Andersen KF, Enevoldsen LH. Sympathetic overactivity in uremia detected by123I-MIBG scintigraphy. Clin Nucl Med 2008; 33: 790-791.
33. Covic A, Goldsmith DJ. Ambulatory blood pressure monitoring in nephrology: focus onBP variability. J Nephrol 1999; 12: 220-229.
34. Parati G, Ochoa JE, Bilo G. Blood pressure variability, cardiovascular risk, and risk forrenal disease progression. Curr Hypertens Rep 2012; 14: 421-431.
35. Parati G, Juan EO, Lombardi C, Bilo G. Assessment and management of blood-pressurevariability. Nat Rev Cardiol 2013; 10: 143-155.
36. Mancia G, Parati G, Pomidossi G, Casadei R, Di Rienzo M, Zanchetti A. Arterialbaroreflexes and blood pressure and heart rate variabilities in humans. Hypertension1986; 8: 147-153.
37. Conway J, Boon N, Davies C, Jones JV, Sleight P. Neural and humoral mechanismsinvolved in blood pressure variability. J Hypertens 1984; 2: 203-208.
38. Mancia G, Grassi G. Mechanisms and clinical implications of blood pressure variability.J Cardiovasc Pharmacol 2000; 35(7 Suppl 4), S15-S19.
39. Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJCAMELOT Investigators. Effect of antihypertensive agents oncardiovascular events in patients with coronary disease and normal blood pressure:the CAMELOT study: a randomized controlled trial. J Am Med Assoc 2004; 292:2217-2225.
40. Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P, Zanchetti AStudy on Cognition and Prognosis in the Elderlystudy group. Stroke prevention with the angiotensin II type 1-receptor blockercandesartan in elderly patients with isolated systolic hypertension: the Study onCognition and Prognosis in the Elderly (SCOPE). J Am Coll Cardiol 2004; 44:1175-1180.
41. Kizer JR, Dahlö f B, Kjeldsen SE, Julius S, Beevers G, de Faire U, Fyhrquist F, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Wachtell K, Edelman JM, Snapinn SM, Harris KE, Devereux RB. Strokereduction in hypertensive adults with cardiac hypertrophy randomized to losartanversus atenolol: the Losartan Intervention for Endpoint Reduction in Hypertensionstudy. Hypertension 2005; 45: 46-52.
42. Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA. Sympathoinhibitory properties ofvarious AT1 receptor antagonists. J Hypertens Suppl 2002; 20: S3-S11.
43. Matsui Y, Eguchi K, O'Rourke MF, Ishikawa J, Shimada K, Kario K.Association between aldosterone induced by antihypertensive medication andarterial stiffness reduction: the J-CORE Study. Atherosclerosis 2011; 215:184-188.
44. Monahan KD, Leuenberger UA, Ray CA. Aldosterone impairs baroreflex sensitivity inhealthy adults. Am J Physiol Heart Circ Physiol 2007; 292: H190-H197.
45. Nasothimiou EG, Karpettas N, Destounis A, Moyssakis I, Tzamouranis D, Stergiou GS.Blood pressure variability assessed by clinic, home and ambulatory measurements.(Abstract). J Hypertens 2011; 29(suppl. A), e448.
46. Karpettas N, Kollias A, Moissakis I, Roussias L, Achimastos A, Stergiou GS. Treatmentinducedchanges in clinic, home and ambulatory blood pressure variability: predictionof changes in target organ damage. (Abstract). J Hypertens 2013; 31 (suppl. A), e38.
47. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of bloodpressure variability. Nat Rev Cardiol 2013; 10: 143-155.